---
title: "Guanhao Biotech: Net profit of 20.4041 million yuan in the first half of 2025, a year-on-year increase of 1.27%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254788364.md"
description: "Guanhao Biotech announced that in the first half of 2025, operating revenue was 201 million yuan, a year-on-year increase of 5.89%. Net profit was 20.4041 million yuan, a year-on-year increase of 1.27%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital"
datetime: "2025-08-27T10:56:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254788364.md)
  - [en](https://longbridge.com/en/news/254788364.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254788364.md)
---

# Guanhao Biotech: Net profit of 20.4041 million yuan in the first half of 2025, a year-on-year increase of 1.27%

Guanhao Biotech announced that in the first half of 2025, the operating income was 201 million yuan, a year-on-year increase of 5.89%. The net profit was 20.4041 million yuan, a year-on-year increase of 1.27%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into capital stock

### Related Stocks

- [300238.CN](https://longbridge.com/en/quote/300238.CN.md)

## Related News & Research

- [Is RFK Jr.'s 'carnivore diet' healthy? Here's what you need to know.](https://longbridge.com/en/news/287079002.md)
- [Investeringsforeningen Nykredit Invest Balance suspender handel med udvalgte afdelinger](https://longbridge.com/en/news/286877547.md)
- [The many shades of a bull market: What they mean for FII, retail flows](https://longbridge.com/en/news/286832825.md)
- [Phase 3-ready cancer biotech Parabilis Medicines files for a $100 million IPO](https://longbridge.com/en/news/286972125.md)
- [Motiva Port Arthur refinery reports crude oil release after pipe issues](https://longbridge.com/en/news/286971029.md)